Description of the national situation of cervical cancer screening in the member states of the European Union

European Journal of Cancer

Volumn 45, Issue 15, 2009, Pages 2685-2708

  Anttila, Ahti ^a   Ronco, Guglielmo ^b  

^a FINNISH CANCER REGISTRY   (Finland)

^b Centre for Cancer Prevention   (Italy)

Author keywords

Cervical cancer; Europe; Screening

Indexed keywords

ARTICLE; AUSTRIA; BELGIUM; BULGARIA; CANCER SCREENING; CYPRUS; CZECH REPUBLIC; DENMARK; ESTONIA; EUROPEAN UNION; FINLAND; FRANCE; GERMANY; HUMAN; HUNGARY; IRELAND; ITALY; LATVIA; LITHUANIA; LUXEMBOURG; MALTA; NATIONAL HEALTH SERVICE; NETHERLANDS; POLAND; PORTUGAL; PRIORITY JOURNAL; ROMANIA; SLOVAKIA; SLOVENIA; SPAIN; SWEDEN; UNITED KINGDOM; UTERINE CERVIX CANCER;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 70349167019     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.07.017     Document Type: Article

References (174)

1. Anttila A., von Karsa L., Aasmaa A., et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 45 15 (2009) 2649-2658
2. Ronco G., van Ballegooijen M., Becker N., et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 45 15 (2009) 2659-2670
3. Arbyn M., Rebolj M., De Kok I., et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 45 15 (2009) 2671-2678
4. Nicula F.A., Anttila A., Neamtiu L., et al. Challenges in starting organised screening programmes for cervical cancer in the new member states. Eur J Cancer 45 15 (2009) 2679-2684
5. Lévy-Bruhl D, King LA, O' Flanagan D, et al. and the country specific VENICE gate keepers and contact points. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey. Eur J Cancer 2009;45(15):2709-2713.
6. Lynge E., Anttila A., Arbyn M., Segnan N., and Ronco G. What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer 45 15 (2009) 2714-2721
7. Breitenecker G., Dinges H.P., Regitnig P., Wiener H., and Vutuc C. Cytopathology in Austria. Cytopathology 15 (2004) 113-118
8. § 132b ASVG, § 61a B-KUVG, § 89 GSVG, § 82 BSVG.
9. .
10. Rasky E. Report "Qualitätsoffensive PAP-Abstrich"; 2007.
11. Vutuc C., Haidinger G., Waldhoer T., Ahmad F., and Breitenecker G. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria. Wien Klin Wochenschr 111 (1999) 354-359
12. .
13. .
14. .
15. Arbyn M., Raifu A.O., Autier P., and Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol 18 (2007) 1708-1715
16. Arbyn M., and Geys H. Trend of cervical cancer mortality in Belgium (1954-94): tentative solution for the certification problem of not specified uterine cancer. Int J Cancer 102 (2002) 649-654
17. Arbyn M., Van Oyen H., Sartor F., Tibaldi F., and Molenberghs G. Description of the influence of age, period and cohort effects on cervical cancer mortality by loglinear Poisson models (Belgium, 1955-94). Arch Public Health 60 (2002) 73-100
18. Arbyn M., and Van Oyen H. Cervical cancer screening in Belgium. Eur J Cancer 36 (2000) 2191-2197
19. Arbyn M., Simoens C., Van Oyen H., et al. Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000). Prev Med 48 (2009) 438-443
20. Hulstaert F, Arbyn M, Huybrechts M, Vinck I, Puddu M, Ramaekers D. Cervical cancer screening and HPV. Brussels: Federaal Kenniscentrum voor de gezondheidszorg; 2006 [Report No.: 38].
21. High Council for Health. Vaccination against human papillomavirus infections: publication no. 8367. Brussels: Haut Conseil de la Santé; Hoge Gezondheidsraad; 2007. p. 1-38. .
22. Arbyn M, Simoens C, Van Damme P, Scharpantgen A, Meijer CJLM, Beutels P. Introduction of HPV vaccination in Belgium, Luxembourg and the Netherlands. Gynecol Obstet Invest [in press].
23. Avramova L, Alexandrova A, Balabanova D, Bradley J, Panayotova Y, Todorova I. Cervical cancer screening in Bulgaria: psychosocial aspects and health systems dimensions. Health Psychology Research Center & Engender Health, Sofia, Report; 2005 [in Bulgarian].
24. Danon Sh, Valerianova Zdr, Ivanova Tzv. Cancer incidence in Bulgaria 2004. National Oncological Hospital, Bulgarian National Cancer Register, Avis-24 Ltd.; 2007.
25. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
26. Kostova P., Zlatkov V., and Danon S. Cervical screening in Bulgaria. An analysis of the main indicators over the period 1970-1994. Akusherstvo i Ginekologiya 37 (1998) 27-29 [in Bulgarian]
27. Kostova P., and Zlatkov V. Effectiveness of cervical screening: expectations and reality. Akysherstvo i Ginekologiya 39 (2000) 23-24 [in Bulgarian]
28. Cancer incidence in the Czech Republic 2005, ÚZIS CR, NOR CR 2008.
29. Bulletin of the Ministry of Public Health, 7/2004, p. 7-11.
30. Bulletin of the Ministry of Public Health, 9/2007, p. 147-51.
31. Tachezy R., and Šmahelová J. Quality assurance of human papillomavirus testing. Coll Antropol 31 Suppl 2 (2007) 61
32. Vonka V., and Hamšíková E. Decision of the HPV vaccine working group of December 12, 2006. Epidemiol Mikrobiol Imunol 56 (2007) 94
33. Prymula R. Novinky v očkování proti HPV. Pediatrie pro Praxi 8 5 (2007) 284-287
34. .
35. National Board of Health. Cervical cancer screening - guidelines 2007 - summary in English. , .
36. In: Aareleid T., and Mägi M. (Eds). Cancer incidence in Estonia 2000 (2003), Estonian Cancer Registry, North Estonian Regional Hospital Foundation, Tallinn
37. Aareleid T., Pukkala E., Thomson H., and Hakama M. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. Eur J Cancer 29A (1993) 745-749
38. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Version 2.0. IARC Cancer Database No. 5. Lyon: International Agency for Research on Cancer; 2004.
39. Raud T., and Klaar U. Pilot project of cervical cancer in Estonia (article in Estonian). Eesti Arst 85 12 (2006) 834-838
40. Rahu M., and McKee M. Epidemiological research labelled as a violation of privacy: the case of Estonia. Int J Epidemiol 37 (2008) 678-682
41. Statistics Estonia. 2007. [accessed 10.11.07].
42. Estonian Gynaecologists' Association. Guidelines for diagnosing and treating precancerous lesions of the cervix uteri (in Estonian); 2008. http://www.ens.ee/juhised/Emakaela%20ravijuhis.pdf [accessed 05.05.08].
43. Anttila A., Pukkala E., Söderman B., Kallio M., Nieminen P., and Hakama M. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: a recent increase in cervical cancer incidence. Int J Cancer 83 (1999) 59-65
44. Finnish Cancer Registry. Cancer in Finland 2004 and 2005. Publication no. 72. Helsinki: Cancer Society of Finland; 2007.
45. Anttila A., and Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer 36 (2000) 2209-2214
46. Anttila A., and Nieminen P. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol 31 Suppl 2 (2007) 17-22
47. Anttila A., Hakama M., Kotaniemi-Talonen L., and Nieminen P. Alternative technologies in cervical cancer screening: a randomised evaluation trial. BMC Public Health 6 (2006) 252
48. Nieminen P., Kotaniemi L., Hakama M., et al. A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: Performance with 470,000 invitations. Int J Cancer 115 (2005) 307-311
49. Kotaniemi-Talonen L., Nieminen P., Hakama M., et al. Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland. Eur J Cancer 43 (2007) 169-174
50. Kotaniemi-Talonen L., Anttila A., Malila N., et al. Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. Eur J Cancer 44 (2008) 565-571
51. Guizard AV, TréTarre B, Col de l'utérus. In: Danon Sh, Valerianova Zdr, Ivanova Tzv, editors. Réseau français des registres de cancer. Cancer incidence in Bulgaria 2004. National Oncological Hospital, Bulgarian National Cancer Register, Avis-24 Ltd.; 2007.
52. Belot A., Grosclaude P., Bossard N., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante publique 56 3 (2008) 159-175
53. Indicateurs de suivi de l'atteinte des 100 objectifs du rapport annexé à la loi du 9 août 2004 relative à la politique de santé publique (objectif 48). [accessed 08.09.08].
54. Rousseau A, Boyet P, Merlière J, Treppoz H, Heules-Bernin B, Ancelle-Park R. Evaluation du dépistage organisé et du dépistage individuel du cancer du col de l'utérus: utilité des données de l'Assurance maladie. BEH, 19.
55. Cahier des charges du dépistage organisé du cancer du col de l'utérus. [accessed 08.09.08].
56. Institut National du Cancer. Etat des lieux du dépistage du cancer du col utérin en France. Rapport et Synthèse; 2007.
57. Avis du comité technique des vaccinations et du conseil supérieur d'hygiène publique de France Section des maladies transmissibles, relatif à la vaccination contre les papillomavirus humains 6,11,16 et 18 - 9 mars; 2007.
58. Avis du Haut conseil de la Santé publique relatif à la vaccination contre les papillomavirus humains 16 et 18 du 14 décembre 2007. [accessed 22.09.08].
59. Schaffer P., Sancho-Garnier H., Fender M., et al. Cervical cancer screening in France. Eur J Cancer 36 17 (2000) 2215-2220
60. Duport N, Haguenoer K, Ancelle-Park R, Bloch J. Dépistage organisé du cancer du col de l'utérus. Evaluation épidémiologique des quatre départements "pilotes" InVS Saint Maurice; 2007. [accessed 08.09.08].
61. Fender M, Schott J, Baldauf JJ, Muller J, Schlund E, Dellenbach P. Une campagne régionale de dépistage du cancer du col de l'utérus. Organisation, résultats à 7 ans et perspectives. Presse Med 2003;32:1545-51.
62. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. A technical report. Berlin, Heidelberg, New York: Springer-Verlag, International Union against Cancer; 1966.
63. Becker N. Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol 129 (2003) 691-702
64. GEKID. Cancer in Germany 2003-2004. Berlin: Robert-Koch-Institut; 2008.
65. Schenck U., and von Karsa L. Cervical cancer screening in Germany. Eur J Cancer 36 (2000) 2221-2226
66. Vereinbarung von Qualitätssicherungsmaßnahmen nach § 135 Abs. 2 SGB V zur zytologischen Untersuchung von Abstrichen der Cervix uteri (Qualitäts-sicherungsvereinbarung Zervix-Zytologie) Dtsch Arztebl 2007;104(36):A-2446/B-2162/C-2094.
67. Schenck U et al. Terminology. International Academy of Cytology Task Force summary. Diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytol 1998;42:5-15.
68. Herbert A., Bergeron C., Wiener H., et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology 18 (2007) 213-219
69. Petry K.-U., Menton S., Menton M., et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 88 (2003) 1570-1577
70. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft e.V. (DKG) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe. AWMF Leitlinienregister NR 032/040. .
71. .
72. .
73. Marquardt K., Büttner H.-H., Broschewitz U., and Barten M. The residual incidence of cervical cancer in Germany (in German). Frauenarzt 45 (2004) 812-815
74. Klug S.J., Hetzer M., and Blettner M. Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors. Eur J Public Health 15 (2005) 70-77
75. Scheffer S., Dauven S., and Sieverding M. Sociodemographic differences in the participation in "early detection of cancer examinations" in Germany - a review. Gesundheitswesen 68 (2006) 139-146
76. Seidel D., Becker N., Rohrmann S., Nimptsch K., and Linseisen J. Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort. J Cancer Res Clin Oncol 135 (2009) 533-541
77. Döbro{combining double acute accent}ssy L, editor. Organized oncology screening programs: QA handbook guideline (in Hungarian) Egészségügyi Minisztérium, Budapest; 2000.
78. Kovacs A, Dobrossy L, Budai A, Boncz I, Cornides A. The state of organized cervical screening program in Hungary in 2006 [Article in Hungarian]. Orv Hetil 2007;148(12):535-40.
79. Boncz I, Sebestyén A, Döbrossy L, Kovács A, Budai A, Székely T. The coverage of cervical screening in Hungary [Article in Hungarian]. Orv Hetil 2007;148(46):2177-82.
80. Kovács A., Döbrossy L., Budai A., Boncz I., and Cornides A. Cervical screening in Hungary: why does the "English model" work but the "Hungarian model" does not?. Eur J Gynaecol Oncol 29 1 (2008) 5-9
81. Vass L, Herbert A, Montanari G, Naryshkin S, Saraiya UB, Smith JH. Obligations to provide appropriate patient management. International Consensus Conference on the Fight against Cervical Cancer, IAC Task Force 11 Summary, Chicago, Illinois, USA. Acta Cytol 2001;45(4):502-8.
82. Annual reports from 2002 to 2008. .
83. Ronco G., Giubilato P., Naldoni C., et al. Activity level and process indicators for cervical cancer screening in Italy. Epidemiol Prev 30 Suppl 3 (2006) 25-38
84. Volante R., and Ronco G. National Survey of the quality of 2nd level in screening for cervical cancer. Epidemiol Prev 30 Suppl 3 (2006) 49-55
85. Ronco G., Giubilato P., Naldoni C., et al. Extension of organised cervical screening programmes in Italy and their process indicators. Epidemiol Prev 31 Suppl 2 (2007) 33-47
86. Volante P., Giubilato P., and Ronco G. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes. Epidemiol Prev 31 Suppl 2 (2007) 61-68
87. Ronco G., Giubilato P., Naldoni C., et al. Extension of organised cervical cancer screening programmes in Italy and their process indicators. Epidemio Prev 32 Suppl 1 (2008) 37-54
88. Volante R., Giubilato P., and Ronco G. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes. Epidemiol Prev 32 Suppl 1 (2008) 69-76
89. Ronco G., Pilutti S., Patriarca S., et al. Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98. Br J Cancer 93 (2005) 376-378
90. Ronco G., Segnan N., Giorgi-Rossi P., et al. Human Papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer randomized controlled trial. J Natl Cancer Inst 98 (2006) 765-774
91. Ronco G., Giorgi-Rossi P., Carozzi F., et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 7 (2006) 547-555
92. Ronco G., Giorgi-Rossi P., Carozzi F., et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone to conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 100 (2008) 492-501
93. Carozzi F., Confortini M., Dalla Palma P., et al. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol 9 (2008) 937-945
94. Scheiden R., Knolle U., Wagener C., Wehenkel A.M., and Capesius C. Cervical cancer screening in Luxembourg. Eur J Cancer 36 Suppl 17 (2000) 2240-2243
95. Scheiden R., Knolle U., Wagener C., Wehenkel A.M., and Capesius C. Cervical cancer screening in Luxembourg: 1990-1999. Cytopathology 14 (2003) 235-240
96. Soost H.J. Nomenklatur und Befundwiedergabe in der gynaekologischen Zytologie. In: Schenck U., and Soost H.-.J. (Eds). Referatband der 10.Fortbildungtagung für klinische Zytologie (1989), Märkl-Druck, München 306-314
97. National Cancer Institute Workshop. Bethesda System for reporting cervical/vaginal cytological diagnosis. J Am Med Assoc 1989;262:931-1-4.
98. Statec: Données de la Population 1990-1999. Service Central de la Statistique et des Etudes Economiques. Luxembourg: Ministère de l'Etat; 2000.
99. Hansen-Koenig D, Roulleaux M, Differding M, Weber G, Wagener Y. Statistiques des Causes de Décès pour les Années 1990-2005. Service des Statistiques de la Direction de la Santé. Luxembourg: Ministère de la Santé; 1999-2005.
100. Convention conclue entre l'Etat du Grand-Duché de Luxembourg et l'Union des caisses de Maladie portant institution d'un programme de médecine préventive pour la vaccination contre Human Papilloma Virus, Mémorial A No. 22, 2008:348-50.
101. Savona Ventura C. Cervical carcinoma in the Maltese population. Health Inform News Issue Number 1996;3.
102. Busuttil R., Dalmas M., and Cilia Vincenti A. Effectiveness of opportunistic screening for cancer of the cervix uteri. Malta Med J 18 3 (2006) 15-20
103. European Cancer Health Indicator Project. [accessed 06.10.08].
104. Dalmas M, Busuttil R. Final report on the Malta Action Project for Eurochip 2, 2008.
105. Demographic Review of the Maltese Islands, 2003. Malta: National Statistics Office; 2004.
106. Demographic Review of the Maltese Islands, 2004. Malta: National Statistics Office; 2005.
107. Demographic Review of the Maltese Islands, 2005. Malta: National Statistics Office; 2006.
108. Dutch Comprehensive Cancer Centres. Cancer registry online: core indicators. [accessed in 2006-2008].
109. National Health Insurance Council. Starting points for the restructuring of the organised cervical cancer screening programme - final decision (in Dutch). Amstelveen, The Netherlands: ZiekenfondsRaad; 1993.
110. Appelman C.L.M., Bruinsma M., Collette C., van Weel C., and Geijer R.M.M. Standard of the Dutch College of GPs concerning cervical smears (1st revision, in Dutch). Huisarts Wet 39 (1996) 134-141
111. Helmerhorst T.J., and Wijnen J.A. Guidelines for the cervical cancer screening programme (In Dutch). Ned Tijdschr Obstet Gynaecol 111 (1998) 264-265
112. van Kemenade F.J., Wiersma T., and Helmerhorst T.J. New version of the pathology practice guideline for cervical cytology: sharpened criteria for adequacy; expanded use of new techniques (in Dutch). Ned Tijdschr Geneeskd 151 (2007) 1283-1286
113. Bulk S., Van Kemenade F.J., Rozendaal L., and Meijer C.J. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 57 (2004) 388-393
114. Rebolj M., van Ballegooijen M., Berkers L.M., and Habbema D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 120 (2007) 806-812
115. Bos A.B., Rebolj M., Habbema J.D., and van Ballegooijen M. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 119 (2006) 2372-2375
116. van Ballegooijen M, Rebolj M, Essink-Bot ML, Meerding WJ, Berkers LM, Habbema JDF. The effects and costs of the Dutch cervical cancer screening programme after the reorganisation (in Dutch). Rotterdam: Erasmus MC, Department of Public Health; 2006.
117. Health Council of the Netherlands. Vaccination against cervical cancer (publication number: 2008/08; in Dutch). The Hague: Health Council of the Netherlands; 2008.
118. Estatísticas de Saúde 2005. Lisboa: INE; 2006. .
119. Risco de morrer em Portugal 2005, vol. II. Lisboa: DGS; 2007. p. 162-74. .
120. Plano Oncológico Nacional 2001-2005; Diário da República no. 190 I série B (5241-5247). .
121. Plano Nacional de Prevenção e Controlo das Doenças Oncológicas 2007-2010. Ministério da Saúde, December 2007. .
122. Plano Nacional de Saúde 2004-2010. Ministério da Saúde; 2004. .
123. Despacho no. 8378/08 da Ministra da Saúde, Diário da República no. 57 II série, 20/05/08. .
124. Manual de rastreio do cancro do colo do útero, Monografia, Administração Regional de Saúde do Centro, Coimbra, Maio; 2005.
125. Registo Oncológico Regional 2005, Monografia, IPOC, Coimbra, Março; 2008.
126. Silva DP, Real Odete, editors. Xth international meeting of gynecology and oncology, proceedings book, ESGO, May 1997.
127. Centrul Naţional pentru Organizarea şi Asigurarea Sistemului Informaţional şi Informatic în Domeniul Sǎnǎtǎţii. Ministerul Sǎnǎtǎţii Publice, Bucureşti.
128. Arbyn M., Primic-Zakelj M., Raifu A.O., et al. The burden of cervical cancer in South-East Europe at the beginning of the 21st century. Coll Antropol 31 2 (2007) 7-10
129. Chiricuţǎ I. "Pap test or Babeş method"? Un dosar neîncheiat al istoriei medicinii: cine a descoperit metoda citodiagnosticului oncologic? In: Galatâr N, editor. Îndreptar de citologie pentru diagnosticul precoce al cancerului colului uterin. Medicalǎ Bucureşti; 1978. p. 34-45.
130. Nicula FA. Resurse de control a calitǎţii epidemiologice a programelor de screening în cancerul de col uterin. In: Nicula FA, Lazǎr L, Costin N, editors. Profilaxia secundarǎ a cancerului de col uterin. Sincron Cluj-Napoca; 1998. p. 11-41.
131. Von Karsa L, Anttila A, Ronco G, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. First Report. IARC; 2008.
132. Şuteu O, Lazǎr L, Irimie AL, et al. Organization and implementation of cervical screening pilot program in County of Cluj, Transylvania. In: Monsonego J, editor. 5th international multidisciplinary congress EUROGIN; 2003, April 13-16; Paris, France. Bologna (Italy): Monduzzi Editore, International proceedings division; 2003. p. 235-9.
133. IARC Handbook of cancer prevention. Cervix cancer screening. IARC&WHO. IARC Press; 2005. p. 121-2.
134. Şuteu O. Elaborarea unui model de program comunitar pentru diagnosticul precoce şi controlul cancerului de col uterin. [Elaboration of a communitary program model for early diagnosis and cervical cancer control] [PhD thesis]. Cluj-Napoca (Romania), I. Haţieganu, University of Medicine and Pharmacy Cluj-Napoca; July 2007, 248p.
135. Şuteu O, Nicula FA, Irimie A, et al. Strategies of cervical cancer prevention in Cluj County, Romania. In: Monsonego J, editor. Update on human papillomavirus infection and cervical pathology. 6th International multidisciplinary congress EUROGIN; 2006, April 23-26; Paris, France. Bologna (Italy): Monduzzi Editore, International Proceedings Division; 2006. p. 69-73.
136. Şuteu O. Organizarea programului de depistare a cancerului de col uterin în judeţul Cluj. In: Irimie Al, Nicula FA, Şuteu O, Coza D, Lupşa L, editors. Programul de prevenţie şi control în patologia oncologicǎ. Medicalǎ Universitarǎ "Iuliu Haţieganu" Cluj-Napoca; 2002. p. 82-109.
137. Arbyn M., Anttila A., Jordan J., et al. European guidelines for quality assurance in cervical cancer screening. 2nd ed. (2008), International Agency for Research on Cancer
138. Pompe-Kirn V., Kovačič J., and Primic-Žakelj M. Epidemiological evaluation of cervical cancer screening in Slovenia up to 1986. Eur J Gynaecol Oncol 13 (1992) 75-82
139. Primic-Žakelj M, Zadnik V, Žagar T. Epidemiologic data on cancer of the cervix uteri in Slovenia. In: Takač I, editor. 50 Years of Gynecologic Cytopathology Laboratory in Maribor. International scientific symposium, Maribor, 17.6.2005. Maribor: University Clinical Center; 2005. p. 151-60.
140. Primic-Žakelj M., Pompe-Kirn V., Škrlec F., and Šelb-Šemerl J. Can we rely on cancer mortality data? Checking the validity of cervical cancer mortality data for Slovenia. Radiol Oncol 35 4 (2001) 243-247
141. Primic-Žakelj M., and Repše-Fokter A. Cervical cancer screening: a Slovenian experience. Coll Antropol 31 Suppl 2 (2007) 23-26
142. Healthcare Databases Act. Official Gazzette of RS No. 65/2000 [in Slovenian]. [accessed 01.09.08].
143. Regulation on conditions that have to be fulfilled by laboratories who read cervical smears [in Slovenian]. Official Gazzette of RS No. 68/01 and 128/2004 [accessed 01.09.08].
144. Instructions for preventive health care in primary reproductive health care. Official Gazzette of RS No. 33/2002 [in Slovenian]. [accessed 01.09.08].
145. Uršič-Vrščaj M, Rakar S, Kovačič J, Kralj B, Možina A. Guidelines for detection, diagnosis, treatment and follow-up of patients with precancerous lesions of uterine cervix. Ljubljana: Medical Chamber of Slovenia; 2000. p. 1-16 [in Slovenian].
146. Pogačnik A, Kirbiš-Srebotnik I, Pohar-Marinšek Ž, Noč G, Primic-Žakelj M. Guideliness for uniform reporting of results of cervical smears and for information system of gynaecologic cytopathology. Ljubljana: Medical Chamber of Slovenia; 2002. p. 1-28 [in Slovenian].
147. Uršič-Vrščaj M, Primic-Žakelj M, Kirar-Fazarinc I, Pogačnik A, Obersnel-Kveder D. Instructions for performing the organised cervical cancer screening programme ZORA in Slovenia. Ljubljana: Institute of Oncology Ljubljana; 2003. p. 1-31 [in Slovenian].
148. Uršič-Vrščaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger D. Guidelines for management of women with abnormal cervical smear. Ljubljana: Society for Gynaecologic Oncology, Colposcopy and Cervical Pathology; 2006. p. 1-32 [in Slovenian].
149. Pogačnik A, Kirbiš-Srebotnik I, Repše-Fokter A, et al. Guidelines for uniform reporting of results of cervical smears (2nd ed.). Ljubljana: Institute of Oncology Ljubljana; 2005. p. 1-24 [in Slovenian].
150. Kirar-Fazarinc I, Uršič-Vrščaj M, Pogačnik A, Obersnel-Kveder D, Ilijaš-Koželj M, Jemec M. Guidelines for smear taking and instructions for performing the organised cervical cancer screening programme ZORA (2nd ed.). Ljubljana: Institute of Oncology Ljubljana; 2005. p. 1-24 [in Slovenian].
151. Primic-Žakelj M, Pogačnik A, Uršič-Vrščaj M. Report on results of the programme ZORA in the years 2006-2007. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry-Programme ZORA; 2007. p. 1-48 [in Slovenian].
152. Castellsague X, de Sanjose S, Aguado T, et al. HPV and cervical cancer in the world. 2007 Report. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Vaccine 25(Suppl 3).
153. López-Abente G, Pollán M, Aragonés N, et al. La situación del cáncer en España. 2005. Planificación sanitaria. Ministerio de Sanidad y Consumo. ISBN: 84-7670-673-1. [accessed 05.16.08].
154. Castells X, Sala M, Ascunce N, Salas D, Zubizarreta R, Casamitjana M. Descripción del Cribado del Cáncer en España. Proyecto DESCRIC. Madrid 2008Plan Nacional para el SNS del MSC. Agència d'Avaluació de Tecnologia i Recerca Mèdiques. Informes de Evaluación de Tecnologias Sanitarias. MINISTERIO DE SANIDAD Y CONSUMO. CENTRO DE PUBLICACIONES.
155. AETS. Uso de la mamografía y de la citología de Papanicolaou para la detección precoz del cáncer de mama y de cérvix uterino en España. Agencia de Evaluación de Tecnología Sanitarias (AETS). Madrid: Instituto de Salud Carlos III; 2002.
156. Puig-Tintoré LM, Castellsagué X, Torné A, et al. Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain. J Low Genit Tract Dis 2008;12(2):82-9.
157. World Health Surveys. Spain: World Health Organization. [accessed 24.05.08].
158. Luengo Matos S., and Muñoz Van Den A. Use of Pap test for cervical cancer screening and factors related with use in Spain. Aten Prim 33 5 (2004) 229-236
159. Spanish government. .
160. Dillner J. Cervical cancer screening in Sweden. Eur J Cancer 36 17 (2000) 2255-2259
161. Socialstyrelsen. Gynekologisk cellprovskontroll. Stockholm, Sweden: National Board of Health and Welfare; 1998 [in Swedish].
162. KVAST Swedish Society of Pathology. Exfoliativ cytologi. Vaginalcytologi. 2006 [Internet]. Stockholm Sweden [cited February 2008]. [in Swedish].
163. Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(Suppl 1):S43-103.
164. Nationellt Kvalitetsregister för Gynekologisk Cellprovskontroll [Internet]. Stockholm: MEB, Karolinska Institutet [cited 2008 December 1] [in Swedish].
165. Andrae B., Kemetli L., Sparen P., et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100 (2008) 622-629
166. Socialstyrelsen. Cancer incidence in Sweden 2005. Stockholm, Sweden: National Board of Health and Welfare; 2007.
167. Cervical Screening Programme England 2007/8 NHS Information Centre Bulletin. [accessed 25.11.08].
168. Lancucki L, Patnick J, Vessey M. A cohort effect in cervical screening coverage? J Med Screen 2008;15:27-9.
169. Sasieni P., Adams J., and Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 89 (2003) 88-93
170. Guidance on the use of liquid-based cytology for cervical screening Technology Appraisal 69 2003 NICE London.
171. [accessed 08.07.08].
172. [accessed 08.07.08].
173. [accessed 08.07.08].
174. Peto J., Gilham C., Fletcher O., and Matthews F.E. The cervical cancer epidemic that screening has prevented in the UK. Lancet 364 (2004) 249-256